• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

个体生物活性凝血因子 VIII 多聚体的分级分离。

Fractionation of individual, biologically active factor VIII multimers.

作者信息

Perret B A, Furlan M, Kneubuehl F, Beck E A

出版信息

Biochim Biophys Acta. 1981 Jun 29;669(1):98-104. doi: 10.1016/0005-2795(81)90228-2.

DOI:10.1016/0005-2795(81)90228-2
PMID:6794637
Abstract

We have designed an electrophoretic system for the fractionation of individual, biologically active multimers of factor VIII. Human factor VIII, purified by gel filtration on Sepharose CL-2B from plasma cryoprecipitate, was submitted to electrophoresis without SDS on 2.0% polyacrylamide gels in 0.04 M Tris/0.06 M Tes buffer, pH 7.5. Staining with Coomassie blue revealed a series of protein bands. Measurement of electrophoretic mobility showed constant size intervals between adjacent bands. Electrophoresis in a second dimension, in the presence of SDS, resulted in an identical order of mobilities, suggesting that the different migration rates of factor VIII proteins in the first electrophoretic system were size- and not charge-dependent. After electrophoresis in the absence of SDS both factor VIII coagulant and ristocetin cofactor activities as well as factor VIII-related antigen were recovered by elution from gel slices. The distribution of activity peaks resembled that of Coomassie-stained factor VIII proteins found in control gels. We thus demonstrate that an electrophoretic fractionation of factor VIII multimers is possible even at neutral pH where factor VIII activities are retained.

摘要

我们设计了一种电泳系统,用于分离具有生物活性的单个凝血因子VIII多聚体。通过在琼脂糖CL - 2B上进行凝胶过滤从血浆冷沉淀中纯化得到的人凝血因子VIII,在不含十二烷基硫酸钠(SDS)的情况下,于pH 7.5的0.04 M Tris/0.06 M Tes缓冲液中的2.0%聚丙烯酰胺凝胶上进行电泳。用考马斯亮蓝染色显示出一系列蛋白条带。电泳迁移率的测量表明相邻条带之间的大小间隔恒定。在存在SDS的情况下进行二维电泳,得到了相同的迁移率顺序,这表明在第一个电泳系统中凝血因子VIII蛋白不同的迁移速率是由大小决定的,而非电荷决定。在不存在SDS的情况下进行电泳后,通过从凝胶切片上洗脱,回收了凝血因子VIII促凝活性、瑞斯托霉素辅因子活性以及凝血因子VIII相关抗原。活性峰的分布类似于在对照凝胶中发现的考马斯亮蓝染色的凝血因子VIII蛋白的分布。因此,我们证明即使在保留凝血因子VIII活性的中性pH条件下,对凝血因子VIII多聚体进行电泳分离也是可行的。

相似文献

1
Fractionation of individual, biologically active factor VIII multimers.个体生物活性凝血因子 VIII 多聚体的分级分离。
Biochim Biophys Acta. 1981 Jun 29;669(1):98-104. doi: 10.1016/0005-2795(81)90228-2.
2
Studies on factor VIII-related protein. II. Estimation of molecular size differences between factor VIII oligomers.凝血因子VIII相关蛋白的研究。II. 凝血因子VIII寡聚体之间分子大小差异的评估。
Biochim Biophys Acta. 1979 May 23;578(1):164-74. doi: 10.1016/0005-2795(79)90124-7.
3
Purification of the factor VIII complex.凝血因子 VIII 复合物的纯化。
Thromb Res. 1984 Aug 15;35(4):431-50. doi: 10.1016/0049-3848(84)90235-4.
4
[Isolation and some properties of factor VIII (antihemophilic factor)].[凝血因子VIII(抗血友病因子)的分离及某些特性]
Acta Haematol Pol. 1976;7(4):283-92.
5
Studies on factor VIII-related protein. I. Ultrastructural and electrophoretic heterogeneity of human factor VIII-related protein.凝血因子VIII相关蛋白的研究。I. 人凝血因子VIII相关蛋白的超微结构和电泳异质性。
Biochim Biophys Acta. 1979 May 23;578(1):155-63. doi: 10.1016/0005-2795(79)90123-5.
6
Variable degradation of factor VIII-related protein in lyophilised concentrates of antihaemophilic factor (AHF).抗血友病因子(AHF)冻干浓缩物中VIII因子相关蛋白的可变降解
Vox Sang. 1978 Jul-Aug;35(1-2):36-40. doi: 10.1111/j.1423-0410.1978.tb02898.x.
7
Preparation and properties of bovine factor VIII (antihemophilic factor).牛因子VIII(抗血友病因子)的制备与特性
Biochemistry. 1980 Feb 5;19(3):401-10. doi: 10.1021/bi00544a001.
8
Studies on factor VIII-related protein. III. Size distribution and carbohydrate content of human and bovine factor VIII.凝血因子VIII相关蛋白的研究。III. 人和牛凝血因子VIII的大小分布及碳水化合物含量。
Biochim Biophys Acta. 1979 Aug 28;579(2):325-33. doi: 10.1016/0005-2795(79)90060-6.
9
Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.因子VIII/血管性血友病因子的二硫键与四级结构
J Clin Invest. 1978 Sep;62(3):702-9. doi: 10.1172/JCI109178.
10
Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody.用人源化沉淀抗体对人凝血因子VIII促凝蛋白进行表征。
Proc Natl Acad Sci U S A. 1982 Mar;79(5):1648-52. doi: 10.1073/pnas.79.5.1648.

引用本文的文献

1
Botrocetin (venom coagglutinin): reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex.蛇毒凝固素(毒液凝集素):与多种多聚体形式的凝血因子VIII大分子复合物发生反应。
Proc Natl Acad Sci U S A. 1983 Mar;80(5):1463-6. doi: 10.1073/pnas.80.5.1463.
2
Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.活化蛋白C对人凝血因子VIII的灭活作用。蛋白S的辅因子活性及血管性血友病因子的保护作用。
J Clin Invest. 1988 Oct;82(4):1236-43. doi: 10.1172/JCI113721.